Type 1/Type 2 Cytokine Paradigm and the Progression of Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Type 1/Type 2 Cytokine Paradigm and the Progression of Pulmonary Fibrosis

Published:2001-07 Issue:1 Volume:120 Page:S5-S8
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Lukacs Nicholas W.,Hogaboam Cory,Chensue Stephen W.,Blease Kate,Kunkel Steven L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference23 articles.

1. Expression of cell II major histocompatibility complex antigen on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis;Kallenberg;J Clin Pathol,1987

2. Desquamative interstitial pneumonia: significance of intranuclear viral-like inclusion bodies;Patchefsky;Ann Intern Med,1971

3. Familial idiopathic pulmonary fibrosis: evidence of lung inflammation in unaffected family members;Bitterman;N Engl J Med,1986

4. Cellular and molecular basis of the asbestos-related diseases;Rom;Am Rev Respir Dis,1991

5. Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages: evidence for sequential production of IL-1 and TNF;Chensue;J Immunol,1989

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis;Pharmaceutical Science Advances;2024-12

2. Changes in T‐cell subsets occur in interstitial lung disease and may contribute to pathology via complicated immune cascade;APMIS;2024-06-11

3. The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis;Medicina;2023-11-10

4. Serum CHI3L1 as a biomarker of interstitial lung disease in rheumatoid arthritis;Frontiers in Immunology;2023-08-17

5. Effect of Shenlong Jianji in the Treatment of Idiopathic Pulmonary Fibrosis: Assessment of Pharmacological Mechanism and Animal Experimental Verification;J BIOL REG HOMEOS AG;2023